Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Anderson

Showing results (361-370 of 407) with videos related to

Pageof 41
Sort By:
Experimental Hematology|December 1, 1995
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxisS Martin-Algarra, M R Bishop, S Tarantolo, et al.
Cancer|December 26, 2001
Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study GroupD O Walterhouse, A S Pappo, K S Baker, et al.
The New England Journal of Medicine|March 10, 1983
Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)J R Anderson, J F Wilson, D T Jenkin, et al.
Sarcoma|June 4, 2008
The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment ProtocolsR B Raney, H M Maurer, J R Anderson, et al.
Journal of Pediatric Hematology/Oncology|February 16, 2002
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study VR B Raney, J R Anderson, F G Barr, et al.
Medical and Pediatric Oncology|January 1, 1994
Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552J L Finlay, J R Anderson, A J Cecalupo, et al.
Cancer|November 1, 1990
A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851A J Gottlieb, J R Anderson, S J Ginsberg, et al.
The EMBO Journal|June 6, 1998
Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lensD T Gilmour, G J Lyon, M B Carlton, et al.
Medical and Pediatric Oncology|June 8, 2000
Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991R B Raney, J R Anderson, J Kollath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IVK S Baker, J R Anderson, M P Link, et al.
Pageof 41

Showing results (361-370 of 407) with videos related to

Sort By:
Pageof 41
Experimental Hematology|December 1, 1995
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxisS Martin-Algarra, M R Bishop, S Tarantolo, et al.
Cancer|December 26, 2001
Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study GroupD O Walterhouse, A S Pappo, K S Baker, et al.
The New England Journal of Medicine|March 10, 1983
Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)J R Anderson, J F Wilson, D T Jenkin, et al.
Sarcoma|June 4, 2008
The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment ProtocolsR B Raney, H M Maurer, J R Anderson, et al.
Journal of Pediatric Hematology/Oncology|February 16, 2002
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study VR B Raney, J R Anderson, F G Barr, et al.
Medical and Pediatric Oncology|January 1, 1994
Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552J L Finlay, J R Anderson, A J Cecalupo, et al.
Cancer|November 1, 1990
A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851A J Gottlieb, J R Anderson, S J Ginsberg, et al.
The EMBO Journal|June 6, 1998
Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lensD T Gilmour, G J Lyon, M B Carlton, et al.
Medical and Pediatric Oncology|June 8, 2000
Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991R B Raney, J R Anderson, J Kollath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IVK S Baker, J R Anderson, M P Link, et al.
Pageof 41